Funding Opportunities

NIH Funding Opportunities

Notice of Expiration of PA-16-091"Small Business Alzheimer's Disease Research (R43/R44)"
Notice NOT-AG-16-035 from the NIH Guide for Grants and Contracts
Wed, 28 Sep 2016 01:31:26 EST

Notice of Expiration of PA-16-092 "Small Business Alzheimer's Disease Research (R41/R42)"
Notice NOT-AG-16-036 from the NIH Guide for Grants and Contracts
Wed, 28 Sep 2016 01:41:22 EST

NIAID Policy: Investigator-Initiated Clinical Trials
Notice NOT-AI-16-084 from the NIH Guide for Grants and Contracts
Wed, 28 Sep 2016 11:42:26 EST

Notice of Availability of the NIEHS Children's Health Exposure Analysis Resource (CHEAR): Laboratory Network (U2C); Data Repository, Analysis and Science Center (U2C); and Coordinating Center (U24)
Notice NOT-ES-17-001 from the NIH Guide for Grants and Contracts
Tue, 27 Sep 2016 11:58:26 EST

Notice of Pre-Application Webinar and Frequently Asked Questions for RFA-HL-17-014 "Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01)
Notice NOT-HL-16-453 from the NIH Guide for Grants and Contracts
Wed, 28 Sep 2016 11:21:42 EST

Notice to Extend PA-14-001 "Exploratory and Developmental Grants to Improve Health Care Quality through Health Information Technology (R21)"
Notice NOT-HS-16-020 from the NIH Guide for Grants and Contracts
Thu, 29 Sep 2016 11:50:00 EST

AHRQ Extends Expiration Date for PA-14-002 and PA-14-004
Notice NOT-HS-16-021 from the NIH Guide for Grants and Contracts
Thu, 29 Sep 2016 11:23:08 EST

Notice of NIMH's Participation in PAR-16-436 "Centers of Excellence in Genomic Science (CEGS) (RM1)"
Notice NOT-MH-16-028 from the NIH Guide for Grants and Contracts
Fri, 30 Sep 2016 10:07:52 EST

Notice of NINR's Participation in PAR-16-391 "Surgical Disparities Research (R01)
Notice NOT-NR-16-008 from the NIH Guide for Grants and Contracts
Wed, 28 Sep 2016 01:55:02 EST

NIH Peer Review Online Briefings for Fellowship and R01 Grant Applicants, and Basic Research Grant Applicants and Reviewers
Notice NOT-OD-16-152 from the NIH Guide for Grants and Contracts
Wed, 28 Sep 2016 01:45:05 EST

Notice of Extension of the Response Date for NOT-OD-16-133 "Metrics to Assess Value of Biomedical Digital Repositories"
Notice NOT-OD-16-153 from the NIH Guide for Grants and Contracts
Thu, 29 Sep 2016 11:35:39 EST

Soon to be Issued Other Transaction (OT) Authority Funding Opportunity for the "Stimulating Peripheral Activity to Relieve Conditions (SPARC): Data and Resource Center (OT3)"
Notice NOT-RM-16-032 from the NIH Guide for Grants and Contracts
Thu, 29 Sep 2016 09:26:35 EST

Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24)
Funding Opportunity RFA-CA-16-502 from the NIH Guide for Grants and Contracts. This limited competition Funding Opportunity Announcement solicits the renewal application for the Chernobyl Tissue Bank Coordinating Center. The Chernobyl Tissue Bank is a collaborative resource that is supported by the National Cancer Institute and another international partner and includes active participation of countries critically affected by the Chernobyl nuclear power plant accident. The objective of the Chernobyl Tissue Bank is to maintain a research resource that supports current and future studies on the biology of thyroid cancer, a major health consequence of the Chernobyl accident. The Chernobyl Tissue Bank Coordinating Center is the critical infrastructure that serves this goal and functions to lead, plan, integrate, and achieve the stated research objectives in collaboration with the participating institutions in the Chernobyl-affected countries.
Fri, 30 Sep 2016 10:31:29 EST

Contraception Research Centers Program (U54)
Funding Opportunity RFA-HD-17-013 from the NIH Guide for Grants and Contracts. The purpose of this announcement is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women. This FOA expands the scope of the former program by calling for Centers to inform contraceptive development and improve contraceptive use by integrating the biomedical research and development with behavioral and social science research, e.g., demography and other population sciences, psychology, economics, and sociology. These Centers also will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Thu, 29 Sep 2016 09:58:51 EST

BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01)
Funding Opportunity RFA-NS-17-003 from the NIH Guide for Grants and Contracts. Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for largescale recording and manipulation of neural activity to enable transformative understanding of dynamic signaling in the nervous system. In particular, we seek exceptionally creative approaches to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful could profoundly change the course of neuroscience research.
Thu, 29 Sep 2016 09:22:24 EST

BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01)
Funding Opportunity RFA-NS-17-004 from the NIH Guide for Grants and Contracts. Although invention and proof-of-concept testing of new technologies are a key component of the BRAIN Initiative, to achieve their potential these technologies must also be optimized through feedback from end-users in the context of the intended experimental use. This seeks applications for the optimization of existing and emerging technologies and approaches that have potential to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and temporal scales, in any region and throughout the entire depth of the brain. This FOA is intended for the iterative refinement of emergent technologies and approaches that have already demonstrated their transformative potential through initial proof-of-concept testing, and are appropriate for accelerated development of hardware and software while scaling manufacturing techniques towards sustainable, broad dissemination and user-friendly incorporation into regular neuroscience practice.
Thu, 29 Sep 2016 09:22:22 EST

BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)
Funding Opportunity RFA-NS-17-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational and clinical studies for recording and/or stimulating devices to treat nervous system disorders and better understand the human brain. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or obtain Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, and a subsequent small clinical study (e.g., Early Feasibility Study). The small clinical study should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical study is expected to provide information that cannot be practically obtained through additional nonclinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, and pursuit of regulatory approval for, and implementation of, a single small clinical study.
Thu, 29 Sep 2016 10:38:37 EST

BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3)
Funding Opportunity RFA-NS-17-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue a small clinical study to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain (e.g., Early Feasibility Study). Clinical studies supported may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board (IRB), or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical study should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical study is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported by this Funding Opportunity include a small clinical study to answer key questions about the function or final design of a device.
Thu, 29 Sep 2016 10:38:21 EST

BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)
Funding Opportunity RFA-NS-17-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage small business concerns (SBCs) to pursue translational non-clinical studies and clinical studies for recording and/or stimulating devices to treat nervous system disorders and thereby better understand the human brain. The program will utilize a cooperative agreement mechanism to support the non-clinical studies necessary for the submission of an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or to obtain Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, and the subsequent small clinical study (e.g., Early Feasibility Study). Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, and pursuit of regulatory approval for, and implementation of, a single small clinical study. The small clinical study should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical study is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use.
Thu, 29 Sep 2016 10:38:35 EST

BRAIN Initiative: SBIR Direct to Phase II Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)
Funding Opportunity RFA-NS-17-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage small business concerns (SBCs) to pursue a small clinical study to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and thereby better understand the human brain (e.g., Early Feasibility Study). Clinical studies supported may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board (IRB), or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical study should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical study is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported by this Funding Opportunity include a small clinical study to answer key questions about the function or final design of a device.
Thu, 29 Sep 2016 10:38:30 EST

NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3)
Funding Opportunity RFA-TR-16-019 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to promote the development of in vitro microphysiological systems in modeling human diseases and conditions that mimic the pathology in major organs and tissues in the human body, when exposed to the extreme environments of space, and the use of these models at the International Space Station-U.S. National Laboratory (ISS-NL) to facilitate the assessment of biomarkers, bioavailability, efficacy, and toxicity of therapeutic agents prior to entry into clinical trials.
Thu, 29 Sep 2016 08:46:51 EST

Kidney Precision Medicine Project - Technology Development and Validation (R41/R42)
Funding Opportunity PA-16-451 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage small businesses to address the technological needs of the Kidney Precision Medicine Project (KPMP). The KPMP will obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) and chronic kidney disease (CKD), create a kidney tissue atlas, define disease subgroups, and identify critical cells, pathways and targets for novel therapies. Proposed technologies are expected to improve the safety of the human kidney biopsy or enhance interrogation of human kidney tissue, thus ensuring that the kidney biopsy yields useful research or clinical information.
Wed, 28 Sep 2016 03:47:52 EST

Kidney Precision Medicine Project - Technology Development and Validation (R43/R44)
Funding Opportunity PA-16-452 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage small businesses to address the technological needs of the Kidney Precision Medicine Project (KPMP). The KPMP will obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) and chronic kidney disease (CKD), create a kidney tissue atlas, define disease subgroups, and identify critical cells, pathways and targets for novel therapies. Proposed technologies are expected to improve the safety of the human kidney biopsy or enhance interrogation of human kidney tissue, thus ensuring that the kidney biopsy yields useful research or clinical information.
Wed, 28 Sep 2016 03:47:57 EST

AHRQ Conference Grant Programs (R13)
Funding Opportunity PA-16-453 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) announces its interest in supporting conferences through the AHRQ Single Year and Multiple Year Conference Grant Programs (R13). AHRQ seeks to support conferences that help to further its mission to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used (http://www.ahrq.gov/funding/policies/foaguidance/index.html.
Thu, 29 Sep 2016 11:23:04 EST

International Bioethics Research Training Program (D43)
Funding Opportunity PAR-16-454 from the NIH Guide for Grants and Contracts. The overall goal of this initiative is to support the development of a sustainable critical mass of bioethics scholars in low and middle income country (LMIC) research intensive institutions with the capabilities to conduct original empirical or conceptual ethics research that addresses challenging issues in health research and research policy in these countries as well as provide research ethics leadership to their institutions, governments and international research organizations. FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate didactic, mentored research and training components to prepare a number of individuals with ethics expertise for positions of scholarship and leadership in health research institutions in the LMIC.
Thu, 29 Sep 2016 10:21:51 EST

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01)
Funding Opportunity PAR-16-455 from the NIH Guide for Grants and Contracts. As part of the Collaborative Research on Addiction at NIH (CRAN) initiative, NIDA, NIAAA, and NCI join to issue this FOA. The purpose of this FOA is to support the development and testing of interventions, models, and/or frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and services.
Fri, 30 Sep 2016 09:24:39 EST

Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34)
Funding Opportunity PAR-16-456 from the NIH Guide for Grants and Contracts. As part of the Collaborative Research on Addiction at NIH (CRAN) initiative, NIDA and NIAAA join to issue this FOA. The purpose of this FOA is to support the development and testing of interventions, models, and/or frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and services.
Fri, 30 Sep 2016 09:24:43 EST